PERICELLULAR PARTIAL OXYGEN PRESSURE (pO₂) MEASUREMENT IN OSTEOPENIC BONE-DERIVED OSTEOBLAST CULTURES

REFERENCES

• Kassem M, Brixen K, Mosekilde L, Eriksen E F. Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994; 54(1)1–6
   PubMedGoogle Scholar
• Marie P J. Cellular and molecular alterations of osteoblasts in human disorders of bone formation. Histol Histopathol 1999; 14: 525–538
   PubMed Web of Science ®Google Scholar
• D'Ippolito G, Schiller P C, Ricordi C, Roos B A, Howard G A. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14(7)1115–1122
   PubMed Web of Science ®Google Scholar
• Rodriguez J P, Garat S, Gajardo H, Pino A M, Seitz G. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamic. J Cell Biochem 1999; 75(39)414–423
   PubMedGoogle Scholar
• Marie P J, De Vernejoul M C, Lomri A. Stimulation of bone formation in osteoporotic patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. J Bone Miner Res 1992; 7(1)103–113
   PubMedGoogle Scholar
• Sasse T, Becker P, Dorfling P, Schuhr T, Brock J. TGF beta-1 mRNA expression and proliferation of human osteoblastic cells in nonosteoporotic and osteoporotic women under influence of TGF beta-1 and IGF-I. Calcif Tissue Int 1998; 62(2)140–147
   PubMed Web of Science ®Google Scholar
• Wong M M, Rao L G, Ly H, Hamilton L, Ish-Shalom S, Sturtridge W, Tong J, McBroom R, Josse R G, Murray T M. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporosis Int 1994; 4: 21–31
   PubMed Web of Science ®Google Scholar
• Marie P J, Sabbagh A, de Vernejoul M C, Lomri A. Osteocalcin and de-oxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab 1989; 69(2)272–279
   PubMedGoogle Scholar
• Lomri A, Marie P J. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women. J Bone Miner Res 1990; 5(11)1149–1155
   PubMed Web of Science ®Google Scholar
• Chavassieux P, Chenu C, Valentin-Opran A, Delmas P D, Boivin G, Chapuy M C, Meunier P J. In vitro exposure to sodium fluoride does not modify activity or proliferation of human osteoblastic cells in primary cultures. J Bone Miner Res 1993; 8(1)37–44
   PubMedGoogle Scholar
• Marie P J, Hott M, Launay J M, Graulat A M, Gueris J. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation. J Clin Endocrinol Metab 1993; 77(3)824–830
   PubMedGoogle Scholar
• Marie P J, de Vernejoul M C, Connes D, Hott M. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest 1991; 88(49)1167–1172
   PubMedGoogle Scholar
• Egrise D, Martin D, Neve P, Vienne A, Verhas M, Schoutens A. Bone blood flow and in vitro proliferation of bone marrow and trabecular bone osteoblast-like cells in ovariectomized rats. Calcif Tissue Int 1992; 50: 336–341
   PubMed Web of Science ®Google Scholar
• Modrowski D, Miravet L, Feuga M, Bannie F, Marie P J. Effect of fluoride on bone and bone cells in ovariectomized rats. J Bone Min Res 1992; 7: 961–969
   PubMed Web of Science ®Google Scholar
• Evans C E, Galasko C S, Ward C. Effect of donor age on the growth in vitro of cells obtained from human trabecular bone. J Orthop Res 1990; 8(2)234–237
   PubMed Web of Science ®Google Scholar
• Kleerekoper M, Avioli L V. Osteoporosis Pathogenesis and Therapy. Metabolic Bone Disease and clinically related disorders, L V Avioli, S M Krane. Academic Press. 1998; 387–409
   Google Scholar
• Fini M, Nicoli N Aldini, Gandolfi M G, Mattioli M Belmonte, Giavaresi G, Zucchini C, De Benedittis A, Amati S, Ravaglioli A, Krajewski A, Rocca M, Guzzardella G A, Biagini G, Giardino R. Biomaterials for orthopaedic surgery in osteoporotic bone: a comparative study in osteopenic rats. Int J Artif Organs 1997; 20(5)291–297
   PubMedGoogle Scholar
• Hara T, Hayashi K, Nakashima Y, Kanemaru T, Iwamoto Y. The effect of hydroxyapatite coating on the bonding of bone to titanium implants in the femora of ovariectomised rats. J Bone Joint Surg Br 1999; 81(4)705–709
   PubMedGoogle Scholar
• Shirota T, Ohno K, Suzuki K, Michi K. The effect of aging on the healing of hydroxylapatite implants. J Oral Maxillofac Surg 1993; 51(1)51–56
   PubMedGoogle Scholar
• Blomqvist J E, Alberius P, Isaksson S, Linde A, Hansson B G. Factors in implant integration failure after bone grafting : an osteometric nad endocrinologic matched analysis. Int J Oral Maxillofac Surg 1996; 25(1)63–68
   PubMedGoogle Scholar
• Soballe K, Hansen E S, Brockstedt-Rasmussen H, Hjortdal V E, Juhl G I, Pedersen C M, Hvid I, Bunger C. Fixation of titanium and hydroxyapatite-coated implants in arthritic osteopenic bone. J Arthroplasty 1991; 6(4)307–316
   PubMedGoogle Scholar
• Torricelli P, Fini M, Rocca M, Giavaresi G, Giardino R. In vitro pathological model of osteopenia to test orthopaedic biomaterials, In press in: Art Cells, Blood Subs, and Immob Biotech 28(2):181–192(2000)
   Google Scholar
• Fini M, Giavaresi G, Torricelli P, Krajewski A, Ravaglioli A, Mattioli M Belmonte, Biagini G, Giardino R. Biocompatibility and osteointegration studies related to osteoporosis: a preliminary in vitro and in vivo study, In Press in: J Bone Joint Surg.
   Google Scholar
• de Vernejoul M C, Belenguer-Prieto R, Kuntz D, Bielakoff J, Miravet L, Ryckewaert A. Bone histological heterogeneity in postmenopausal osteoporosis: a sequential histomorphometric study. Bone 1987; 8(6)339–342
   PubMedGoogle Scholar
• Byers R J, Denton J, Hoyland J A, Freemont A J. Differential patterns of osteoblast dysfunction in trabecular bone in patients with established osteoporosis. J Clin Pathol 1997; 50(9)760–764
   PubMedGoogle Scholar
• Rehman M T, Hoyland J A, Denton J, Freemont A J. Histomorphometric classification of postmenopausal osteoporosis: implications for the management of osteoporosis. J Clin Pathol 1995; 48(3)229–235
   PubMedGoogle Scholar
• Giavaresi G, Torricelli P, Fini M, Giardino R. Pericellular pO2 as an alternative method to test cytotoxicity. Art Cells, Blood Subs, and Immob Biotech 1996; 24(6)579–586
   PubMed Web of Science ®Google Scholar
• Rocca M, Giavaresi G, Nicoli N Aldini, Fini M, Marcacci M, Zaffagnini S, Giardino R. pO2 measurement in an experimental patellar tendon autograft pro-anterior cruciate ligament. Int J Artif Organs 1998; 21(3)174–178
   PubMedGoogle Scholar
• Jonsson K B, Frost A, Nilsson O, Ljunghall S, Ljunggren O. Three different isolation techniques for primary culture of human osteoblast-like cells: a comparison. Acta Orthop Scand 1999; 70: 365–373
   PubMed Web of Science ®Google Scholar
• Steibrech D S, Mehrara B J, Saadeh P B, Chin G, Dudziak M E, Gerrets R P, Gittes G K, Longaker M T. Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 1999; 104(3)738–747
   PubMedGoogle Scholar
• Kapitola J, Kubickova J, Andrle J. Blood flow and mineral content of the tibia of female and male rats: changes following castration and/or administration of estradiol or testosterone. Bone 1995; 16(1)69–72
   PubMedGoogle Scholar
• Kapitola J, Zak J. Effect of pamidronate on bone blood flow in oophorectomized rats. Physiol Res 1998; 47(4)237–240
   PubMedGoogle Scholar
• Laroche M, Barbier A, Ludot I, Vernhet C, Thiechart M, Viguier G, Mazieres B. Effect of ovariectomy on intraosseous vascularization and bone remodelling in rats: action of tiludronate. Osteoporosis Int 1996; 6(2)127–129
   PubMedGoogle Scholar